🔗 Permalink

Inventor profile of:

David Wraith

City:

Bristol

Country:

United Kingdom

Published Applications:

Last publication date:

2019-09-12

Top Assignees for applications by David Wraith

The entities that hold a legal rights for patent applications filed by inventor Wraith David:

Apitope Technology (Bristol) Limited 6 Bristol, United Kingdom
APITOPE INTERNATIONAL NV 2 Diepenbeek, Belgium
Apitope International NV 2 Diepenbeck, Belgium
APITOPE TECHNOLOGY (BRISTOL) LIMITED 2 Chepstow, United Kingdom

Recent patent applications by Wraith David

David Wraith from Bristol, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-09-12

US20190275126A1

Human necessities

PEPTIDE

#2 | 2018-11-15

US20180327463A1

Chemistry; metallurgy

Peptides

#3 | 2018-03-29

US20180086802A1

Chemistry; metallurgy

Myelin oligodendrocyte glycoprotein (MOG) peptide

#4 | 2016-09-15

US20160263188A1

Human necessities

Methods of using myelin basis protein peptide compositions

#5 | 2016-06-30

US20160185833A1

Chemistry; metallurgy

Peptides

#6 | 2015-12-10

US20150353616A1

Chemistry; metallurgy

Myelin oligodendrocyte glycoprotein peptides

#7 | 2015-12-10

US20150352197A1

Human necessities

PEPTIDE

#8 | 2015-10-29

US20150306192A1

Human necessities

MODIFIED FVIII APITOPE PEPTIDES

#9 | 2015-03-12

US20150071967A1

Human necessities

Tolerisation-Inducing Composition

#10 | 2014-06-12

US20140161832A1

Human necessities

Methods of using myelin basic protein peptide compositions

#11 | 2013-06-20

US20130156798A1

Human necessities

Peptide composition

#12 | 2012-05-17

US20120121625A1

Chemistry; metallurgy

Modified factor VIII peptides

#13 | 2010-12-23

US20100323966A1

Chemistry; metallurgy

FVIII peptides and their use in tolerising haemophiliacs

#14 | 2010-11-11

US20100286054A1

Human necessities

Myelin basic protein peptide composition

#15 | 2010-05-27

US20100129853A1

Physics

DISEASE MARKERS

InventorID:

298752 ⎘